281 related articles for article (PubMed ID: 33602304)
1. U-IMD: the first Unified European registry for inherited metabolic diseases.
Opladen T; Gleich F; Kozich V; Scarpa M; Martinelli D; Schaefer F; Jeltsch K; Juliá-Palacios N; García-Cazorla Á; Dionisi-Vici C; Kölker S
Orphanet J Rare Dis; 2021 Feb; 16(1):95. PubMed ID: 33602304
[TBL] [Abstract][Full Text] [Related]
2. The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys.
Lampe C; Dionisi-Vici C; Bellettato CM; Paneghetti L; van Lingen C; Bond S; Brown C; Finglas A; Francisco R; Sestini S; Heard JM; Scarpa M;
Orphanet J Rare Dis; 2020 Dec; 15(1):341. PubMed ID: 33272301
[TBL] [Abstract][Full Text] [Related]
3. Social and medical needs of rare metabolic patients: results from a MetabERN survey.
Sestini S; Paneghetti L; Lampe C; Betti G; Bond S; Bellettato CM; Maurizio S
Orphanet J Rare Dis; 2021 Aug; 16(1):336. PubMed ID: 34344397
[TBL] [Abstract][Full Text] [Related]
4. Impact of the SARS-CoV-2 pandemic on the health of individuals with intoxication-type metabolic diseases-Data from the E-IMD consortium.
Mütze U; Gleich F; Barić I; Baumgartner M; Burlina A; Chapman KA; Chien YH; Cortès-Saladelafont E; De Laet C; Dobbelaere D; Eysken F; Gautschi M; Santer R; Häberle J; Joaquín C; Karall D; Lindner M; Lund AM; Mühlhausen C; Murphy E; Roland D; Ruiz Gomez A; Skouma A; Grünert SC; Wagenmakers M; Garbade SF; Kölker S; Boy N
J Inherit Metab Dis; 2023 Mar; 46(2):220-231. PubMed ID: 36266255
[TBL] [Abstract][Full Text] [Related]
5. Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey.
Stepien KM; Kieć-Wilk B; Lampe C; Tangeraas T; Cefalo G; Belmatoug N; Francisco R; Del Toro M; Wagner L; Lauridsen AG; Sestini S; Weinhold N; Hahn A; Montanari C; Rovelli V; Bellettato CM; Paneghetti L; van Lingen C; Scarpa M
Front Med (Lausanne); 2021; 8():652358. PubMed ID: 33738294
[TBL] [Abstract][Full Text] [Related]
6. On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases.
Summar ML; Endo F; Kölker S
Mol Genet Metab; 2014; 113(1-2):105-8. PubMed ID: 25261246
[TBL] [Abstract][Full Text] [Related]
7. Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium.
Kölker S; Dobbelaere D; Häberle J; Burgard P; Gleich F; Summar ML; Hannigan S; Parker S; Chakrapani A; Baumgartner MR;
JIMD Rep; 2015; 22():29-38. PubMed ID: 25701269
[TBL] [Abstract][Full Text] [Related]
8. One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN.
Paneghetti L; Bellettato CM; Sechi A; Stepien KM; Scarpa M
Orphanet J Rare Dis; 2022 Mar; 17(1):109. PubMed ID: 35246188
[TBL] [Abstract][Full Text] [Related]
9. 100 years of inherited metabolic disorders in Austria-A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021.
Ramoser G; Caferri F; Radlinger B; Brunner-Krainz M; Herbst S; Huemer M; Hufgard-Leitner M; Kircher SG; Konstantopoulou V; Löscher W; Möslinger D; Plecko B; Spenger J; Stulnig T; Sunder-Plassmann G; Wortmann S; Scholl-Bürgi S; Karall D;
J Inherit Metab Dis; 2022 Mar; 45(2):144-156. PubMed ID: 34595757
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the quality of clinical data collection for a pan-Canadian cohort of children affected by inherited metabolic diseases: lessons learned from the Canadian Inherited Metabolic Diseases Research Network.
Tingley K; Lamoureux M; Pugliese M; Geraghty MT; Kronick JB; Potter BK; Coyle D; Wilson K; Kowalski M; Austin V; Brunel-Guitton C; Buhas D; Chan AKJ; Dyack S; Feigenbaum A; Giezen A; Goobie S; Greenberg CR; Ghai SJ; Inbar-Feigenberg M; Karp N; Kozenko M; Langley E; Lines M; Little J; MacKenzie J; Maranda B; Mercimek-Andrews S; Mohan C; Mhanni A; Mitchell G; Mitchell JJ; Nagy L; Napier M; Pender A; Potter M; Prasad C; Ratko S; Salvarinova R; Schulze A; Siriwardena K; Sondheimer N; Sparkes R; Stockler-Ipsiroglu S; Trakadis Y; Turner L; Van Karnebeek C; Vallance H; Vandersteen A; Walia J; Wilson A; Wilson BJ; Yu AC; Yuskiv N; Chakraborty P;
Orphanet J Rare Dis; 2020 Apr; 15(1):89. PubMed ID: 32276663
[TBL] [Abstract][Full Text] [Related]
11. Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.
Kölker S; Gleich F; Mütze U; Opladen T
Front Endocrinol (Lausanne); 2022; 13():832063. PubMed ID: 35317224
[TBL] [Abstract][Full Text] [Related]
12. The challenge of understanding and predicting phenotypic diversity in urea cycle disorders.
Posset R; Zielonka M; Gleich F; Garbade SF; Hoffmann GF; Kölker S;
J Inherit Metab Dis; 2023 Nov; 46(6):1007-1016. PubMed ID: 37702610
[TBL] [Abstract][Full Text] [Related]
13. [Information and retrieval diagnostic system for inherited metabolic diseases].
Krasnopol'skaia KD; Evdokimenkov VN; Tishkanina SV
Vestn Ross Akad Med Nauk; 2000; (5):11-9. PubMed ID: 10881656
[TBL] [Abstract][Full Text] [Related]
14. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability.
Kupelian PA; Willoughby TR; Meeks SL; Forbes A; Wagner T; Maach M; Langen KM
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1291-6. PubMed ID: 16029784
[TBL] [Abstract][Full Text] [Related]
15. Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities.
Hazan G; Hershkovitz E; Staretz-Chacham O
Orphanet J Rare Dis; 2020 Nov; 15(1):331. PubMed ID: 33239050
[TBL] [Abstract][Full Text] [Related]
16. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening.
Bower A; Imbard A; Benoist JF; Pichard S; Rigal O; Baud O; Schiff M
Sci Rep; 2019 Oct; 9(1):14098. PubMed ID: 31575911
[TBL] [Abstract][Full Text] [Related]
18. The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results.
Bassanese G; Wlodkowski T; Servais A; Heidet L; Roccatello D; Emma F; Levtchenko E; Ariceta G; Bacchetta J; Capasso G; Jankauskiene A; Miglinas M; Ferraro PM; Montini G; Oh J; Decramer S; Levart TK; Wetzels J; Cornelissen E; Devuyst O; Zurowska A; Pape L; Buescher A; Haffner D; Marcun Varda N; Ghiggeri GM; Remuzzi G; Konrad M; Longo G; Bockenhauer D; Awan A; Andersone I; Groothoff JW; Schaefer F
Orphanet J Rare Dis; 2021 Jun; 16(1):251. PubMed ID: 34078418
[TBL] [Abstract][Full Text] [Related]
19. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for inherited metabolic diseases.
Yilmaz BS; Gurung S; Perocheau D; Counsell J; Baruteau J
J Mother Child; 2020 Nov; 24(2):53-64. PubMed ID: 33554501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
